Differential immune response to gangliosides in Guillain-Barre syndrome patients from Japan and The Netherlands

被引:14
作者
Ang, CW
Koga, M
Jacobs, BC
Yuki, N
van der Meché, FGA
van Doorn, PA
机构
[1] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Neurol, NL-3015 GD Rotterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Immunol, NL-3015 GD Rotterdam, Netherlands
[4] Dokkyo Univ, Sch Med, Dept Neurol, Mibu, Tochigi 3210293, Japan
关键词
gangliosides; ELISA; demography; isotype; Guillain-Barre syndrome;
D O I
10.1016/S0165-5728(01)00426-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-ganglioside antibodies are consistently found in Guillain-Barre syndrome (GBS) patients from different geographical parts of the world. Several studies indicated differences in relative frequencies of anti-ganglioside reactivity and isotype distribution between GBS patients from Asia and from Europe. We investigated antibody reactivity against the gangliosides GM1, GM1b and GalNAc-GD1a in GBS patients from Japan and The Netherlands in two different laboratories. The proportion of GBS patients with anti-ganglioside antibodies did not differ between the two countries. GBS patients from The Netherlands more frequently had cross-reacting anti-GaINAc-GD1a/anti-GM1b antibodies and a stronger IgM anti-ganglioside response. Our findings indicate that geographical determined factors, dependent on either the host or the triggering infectious agent, determine the isotype distribution and fine specificity of anti-ganglioside antibodies in GBS patients. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 26 条
[1]   Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-GalNAc-GD1a antibodies [J].
Ang, CW ;
Yuki, N ;
Jacobs, BC ;
Koga, M ;
Van Doorn, PA ;
Schmitz, PIM ;
Van der Meché, FGA .
NEUROLOGY, 1999, 53 (09) :2122-2127
[2]  
Asbury AK, 1990, ANN NEUROL S, V27, P21
[3]  
Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297
[4]   Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections [J].
Hao, Q ;
Saida, T ;
Kuroki, S ;
Nishimura, M ;
Nukina, M ;
Obayashi, H ;
Saida, K .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 81 (1-2) :116-126
[5]  
Hao Q, 1999, ANN NEUROL, V45, P758
[6]   GUILLAIN-BARRE-SYNDROME IN NORTHERN CHINA - RELATIONSHIP TO CAMPYLOBACTER-JEJUNI INFECTION AND ANTI-GLYCOLIPID ANTIBODIES [J].
HO, TW ;
MISHU, B ;
LI, CY ;
GAO, CY ;
CORNBLATH, DR ;
GRIFFIN, JW ;
ASBURY, AK ;
BLASER, MJ ;
MCKHANN, GM .
BRAIN, 1995, 118 :597-605
[7]  
Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO
[8]  
2-6
[9]   Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barre syndrome [J].
Jacobs, BC ;
vanDoorn, PA ;
Groeneveld, JHM ;
TioGillen, AP ;
vanderMeche, FGA .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (06) :641-643
[10]   SERUM ANTI-GQ(1B) IGG ANTIBODIES RECOGNIZE SURFACE EPITOPES ON CAMPYLOBACTER-JEJUNI FROM PATIENTS WITH MILLER-FISHER-SYNDROME [J].
JACOBS, BC ;
ENDTZ, HP ;
VANDERMECHE, FGA ;
HAZENBERG, MP ;
ACHTEREEKTE, HAM ;
VANDOORN, PA .
ANNALS OF NEUROLOGY, 1995, 37 (02) :260-264